Kelyniam Global, Inc. operates as a medical device manufacturing company, which engages in the production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers. It provides replicated cranial implants to replace damaged bone structures. The company was founded on December 30, 2005 and is headquartered in Canton, CT.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Kelyniam Global Inc market cap is $4.51M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kelyniam Global Inc 52 week high is $0.30 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kelyniam Global Inc 52 week low is $0.09 as of November 22, 2026.
Kelyniam Global Inc stock price today is $0.09.
Kelyniam Global Inc stock price yesterday was $0.096.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Kelyniam Global Inc's P/E ratio is -112.5.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Kelyniam Global Inc P/B ratio is 6.3025.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Kelyniam Global Inc 50-day moving average is $0.114.